Company Filing History:
Years Active: 2022-2023
Title: Brendan Galvin: Innovator in Genetic Engineering
Introduction
Brendan Galvin is a notable inventor based in San Bruno, CA (US). He has made significant contributions to the field of genetic engineering, particularly in the development of safe harbor loci for transgene expression.
Latest Patents
Brendan holds 2 patents that focus on safe harbor loci. His latest patents provide methods for identifying and using these loci to engineer cells to express transgenes. The safe harbor loci exhibit increased transgene knock-in efficiency and allow for stable expression of transgenes in engineered cells. Additionally, guide ribonucleic acids (gRNAs) may be utilized for the insertion of transgenes in these safe harbor loci.
Career Highlights
Brendan is currently employed at Arsenal Biosciences, Inc., where he continues to advance his research in genetic engineering. His work has the potential to impact various applications in biotechnology and medicine.
Collaborations
Brendan collaborates with talented individuals such as Xinying Zheng and Somya Khare, contributing to a dynamic research environment.
Conclusion
Brendan Galvin's innovative work in genetic engineering, particularly with safe harbor loci, showcases his commitment to advancing the field. His contributions are paving the way for future developments in transgene expression and cellular engineering.